-
1
-
-
4444357091
-
Neuroblastoma
-
Bast RC, Kufe DW, Pollock RE, et al eds, London, BC Decker
-
Matthay KK, Yamashiro D: Neuroblastoma, in Bast RC, Kufe DW, Pollock RE, et al (eds): Cancer Medicine. London, BC Decker, 2000, pp 2185-2197
-
(2000)
Cancer Medicine
, pp. 2185-2197
-
-
Matthay, K.K.1
Yamashiro, D.2
-
2
-
-
0033554684
-
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
-
Matthay KK, Villablanca JG, Seeger RC, et al: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341:1165-1173, 1999
-
(1999)
N Engl J Med
, vol.341
, pp. 1165-1173
-
-
Matthay, K.K.1
Villablanca, J.G.2
Seeger, R.C.3
-
3
-
-
0018908664
-
Radiolabeled adrenergic neuron-labeling agents: Adrenomedullary imaging with 131-I-iodobenzylguanidine
-
Wieland DM, Wu JL, Brown LE, et al: Radiolabeled adrenergic neuron-labeling agents: Adrenomedullary imaging with 131-I-iodobenzylguanidine. J Nucl Med 21:349-353, 1980
-
(1980)
J Nucl Med
, vol.21
, pp. 349-353
-
-
Wieland, D.M.1
Wu, J.L.2
Brown, L.E.3
-
4
-
-
0031961810
-
Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma
-
Matthay KK, DeSantes K, Hasegawa B, et al: Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J Clin Oncol 16:229-236, 1998
-
(1998)
J Clin Oncol
, vol.16
, pp. 229-236
-
-
Matthay, K.K.1
DeSantes, K.2
Hasegawa, B.3
-
5
-
-
0032585696
-
131I- metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: A mono-institutional experience with 43 patients
-
Garaventa A, Bellagamba O, Lo Piccolo MS, et al: 131I- metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: A mono-institutional experience with 43 patients. Br J Cancer 81:1378-1384, 1999
-
(1999)
Br J Cancer
, vol.81
, pp. 1378-1384
-
-
Garaventa, A.1
Bellagamba, O.2
Lo Piccolo, M.S.3
-
6
-
-
0025868778
-
Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: Results of the German Neuroblastoma Trial
-
Klingebiel T, Berthold F, Treuner J, et al: Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: Results of the German Neuroblastoma Trial. Med Pediatr Oncol 19:84-88, 1991
-
(1991)
Med Pediatr Oncol
, vol.19
, pp. 84-88
-
-
Klingebiel, T.1
Berthold, F.2
Treuner, J.3
-
7
-
-
0026357907
-
Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma
-
Hutchinson RJ, Sisson JC, Miser JS, et al: Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma. J Nucl Biol Med 35:237-240, 1991
-
(1991)
J Nucl Biol Med
, vol.35
, pp. 237-240
-
-
Hutchinson, R.J.1
Sisson, J.C.2
Miser, J.S.3
-
8
-
-
0025984214
-
Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy
-
Voute PA, Hoefnagel CA, de Kraker J, et al: Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy. Prog Clin Biol Res 366:439-445, 1991
-
(1991)
Prog Clin Biol Res
, vol.366
, pp. 439-445
-
-
Voute, P.A.1
Hoefnagel, C.A.2
de Kraker, J.3
-
9
-
-
0027093713
-
Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: A United Kingdom Children's Cancer Study Group investigation
-
Lashford LS, Lewis IJ, Fielding SL, et al: Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: A United Kingdom Children's Cancer Study Group investigation. J Clin Oncol 10:1889-1896, 1992
-
(1992)
J Clin Oncol
, vol.10
, pp. 1889-1896
-
-
Lashford, L.S.1
Lewis, I.J.2
Fielding, S.L.3
-
10
-
-
0026405073
-
Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: A phase II study in 26 patients. Societe Francaise d'Oncologie Pediatrique and Nuclear Medicine Co-investigators
-
Lumbroso J, Hartmann O, Schlumberger M: Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: A phase II study in 26 patients. Societe Francaise d'Oncologie Pediatrique and Nuclear Medicine Co-investigators. J Nucl Biol Med 35:220-223, 1991
-
(1991)
J Nucl Biol Med
, vol.35
, pp. 220-223
-
-
Lumbroso, J.1
Hartmann, O.2
Schlumberger, M.3
-
11
-
-
0028169019
-
131I-MIBG as a first-line treatment in high-risk neuroblastoma patients
-
Hoefnagel CA, De Kraker J, Valdes Olmos RA, et al: 131I-MIBG as a first-line treatment in high-risk neuroblastoma patients. Nucl Med Commun 15: 712-717, 1994
-
(1994)
Nucl Med Commun
, vol.15
, pp. 712-717
-
-
Hoefnagel, C.A.1
De Kraker, J.2
Valdes Olmos, R.A.3
-
12
-
-
0035099689
-
Treatment of advanced neuroblastoma: Feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy
-
Mastrangelo S, Tornesello A, Diociaiuti L, et al: Treatment of advanced neuroblastoma: Feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Br J Cancer 84:460-464, 2001
-
(2001)
Br J Cancer
, vol.84
, pp. 460-464
-
-
Mastrangelo, S.1
Tornesello, A.2
Diociaiuti, L.3
-
13
-
-
0032145478
-
Treatment of neuroblastoma stage 4 with 131I-metaiodo-benzylguanidine, high-dose chemotherapy and immunotherapy: A pilot study
-
Klingebiel T, Bader P, Bares R, et al: Treatment of neuroblastoma stage 4 with 131I-metaiodo-benzylguanidine, high-dose chemotherapy and immunotherapy: A pilot study. Eur J Cancer 34: 1398-1402, 1998
-
(1998)
Eur J Cancer
, vol.34
, pp. 1398-1402
-
-
Klingebiel, T.1
Bader, P.2
Bares, R.3
-
14
-
-
0037089597
-
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma
-
Yanik GA, Levine JE, Matthay KK, et al: Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma. J Clin Oncol 20:2142-2149, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 2142-2149
-
-
Yanik, G.A.1
Levine, J.E.2
Matthay, K.K.3
-
15
-
-
33644846781
-
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study
-
Matthay KK, Tan JC, Villablanca JG, et al: Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study. J Clin Oncol 24: 500-506, 2006
-
(2006)
J Clin Oncol
, vol.24
, pp. 500-506
-
-
Matthay, K.K.1
Tan, J.C.2
Villablanca, J.G.3
-
16
-
-
18844423539
-
Feasibility of dosimetry-based high-dose 131I-metaiodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma
-
Gaze MN, Chang YC, Flux GD, et al: Feasibility of dosimetry-based high-dose 131I-metaiodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma. Cancer Biother Radiopharm 20:195-199, 2005
-
(2005)
Cancer Biother Radiopharm
, vol.20
, pp. 195-199
-
-
Gaze, M.N.1
Chang, Y.C.2
Flux, G.D.3
-
17
-
-
2942702182
-
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma
-
Dubois SG, Messina J, Maris JM, et al: Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma. J Clin Oncol 22:2452-2460, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 2452-2460
-
-
Dubois, S.G.1
Messina, J.2
Maris, J.M.3
-
18
-
-
0035205508
-
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG
-
Matthay KK, Panina C, Huberty J, et al: Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG. J Nucl Med 42: 1713-1721, 2001
-
(2001)
J Nucl Med
, vol.42
, pp. 1713-1721
-
-
Matthay, K.K.1
Panina, C.2
Huberty, J.3
-
19
-
-
13444303822
-
Tumor response and toxicity with multiple infusions of high dose (131)I-MIBG for refractory neuroblastoma
-
Howard JP, Maris JM, Kersun LS, et al: Tumor response and toxicity with multiple infusions of high dose (131)I-MIBG for refractory neuroblastoma. Pediatr Blood Cancer 44:232-239, 2005
-
(2005)
Pediatr Blood Cancer
, vol.44
, pp. 232-239
-
-
Howard, J.P.1
Maris, J.M.2
Kersun, L.S.3
-
20
-
-
0027239723
-
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
-
Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477, 1993
-
(1993)
J Clin Oncol
, vol.11
, pp. 1466-1477
-
-
Brodeur, G.M.1
Pritchard, J.2
Berthold, F.3
-
21
-
-
33750483287
-
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma
-
Messina JA, Cheng SC, Franc BL, et al: Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma. Pediatr Blood Cancer 47: 865-874, 2006
-
(2006)
Pediatr Blood Cancer
, vol.47
, pp. 865-874
-
-
Messina, J.A.1
Cheng, S.C.2
Franc, B.L.3
-
22
-
-
0034671344
-
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: A Children's Cancer Group Study
-
Seeger RC, Reynolds CP, Gallego R, et al: Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: A Children's Cancer Group Study. J Clin Oncol 18:4067-4076, 2000
-
(2000)
J Clin Oncol
, vol.18
, pp. 4067-4076
-
-
Seeger, R.C.1
Reynolds, C.P.2
Gallego, R.3
-
23
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
24
-
-
0000336139
-
Regression models and life tables
-
Cox DRB: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
-
(1972)
J R Stat Soc B
, vol.34
, pp. 187-220
-
-
Cox, D.R.B.1
-
25
-
-
0038649080
-
Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma
-
Weiss B, Vora A, Huberty J, et al: Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma. J Pediatr Hematol Oncol 25:543-547, 2003
-
(2003)
J Pediatr Hematol Oncol
, vol.25
, pp. 543-547
-
-
Weiss, B.1
Vora, A.2
Huberty, J.3
-
26
-
-
0030919377
-
Neuroblastoma in adults and adolescents: An indolent course with poor survival
-
Franks LM, Bollen A, Seeger RC, et al: Neuroblastoma in adults and adolescents: An indolent course with poor survival. Cancer 79:2028-2035, 1997
-
(1997)
Cancer
, vol.79
, pp. 2028-2035
-
-
Franks, L.M.1
Bollen, A.2
Seeger, R.C.3
-
27
-
-
0027528534
-
Second tumors after treatment of childhood malignancies
-
Robison LL, Mertens A: Second tumors after treatment of childhood malignancies. Hematol Oncol Clin North Am 7:401-415, 1993
-
(1993)
Hematol Oncol Clin North Am
, vol.7
, pp. 401-415
-
-
Robison, L.L.1
Mertens, A.2
-
28
-
-
0035253384
-
How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review
-
Kushner BH, Meyers PA: How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. J Clin Oncol 19:870-880, 2001
-
(2001)
J Clin Oncol
, vol.19
, pp. 870-880
-
-
Kushner, B.H.1
Meyers, P.A.2
-
29
-
-
0037445124
-
Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: A case-control study by the Societe Francaise d'Oncologie Pediatrique
-
Le Deley MC, Leblanc T, Shamsaldin A, et al: Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: A case-control study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 21:1074-1081, 2003
-
(2003)
J Clin Oncol
, vol.21
, pp. 1074-1081
-
-
Le Deley, M.C.1
Leblanc, T.2
Shamsaldin, A.3
|